reports
- ABGSC Capital Goods Research
- Mikkel Løgsted
- ABGSC Capital Goods Research
- Mikkel Løgsted
FLSmidth 2025 Annual Report: Solid performance provides strong foundat...
FLSmidth 2025 Annual Report: Solid performance provides strong foundation for the next phase, focused on accelerating growth COMPANY ANNOUNCEMENT NO. 13-2026FLSmidth & Co. A/S18 February 2026Copenhagen, Denmark Today, the Board of Directors of FLSmidth & Co. A/S (FLSmidth) have approved the 2025 Annual Report. In 2025, FLSmidth reported a total revenue DKK 14,612m and an Adjusted EBITA margin of 15.9%. Highlights in 2025: Order intake increased organically by 3% compared to 2024 driven by the Service and Pumps, Cyclones & Valves (PC&V) businesses. Total order intake decreased by 2% ...
FLSmidth: Transactions under share buy-back programme
FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 12-2026FLSmidth & Co. A/S18 February 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of R...
FLSmidth announces intention to initiate a new share buy-back programm...
FLSmidth announces intention to initiate a new share buy-back programme of up to DKK 1.0 billion COMPANY ANNOUNCEMENT NO. 11-2026FLSmidth & Co. A/S17 February 2026Copenhagen, Denmark FLSmidth & Co. A/S (“FLSmidth”) today announces the intention to initiate a new share buy-back programme of up to DKK 1.0 billion after the release of its Q1 2026 financial results. The company’s intention to initiate a share buy-back programme is supported by a solid balance sheet, sound cash-flow generation and the expected net cash proceeds from the sale of the company’s former corporate headquarters to...
- ABGSC Capital Goods Research
- Henrik Bartnes
- Petter Nystrøm
- ABGSC Capital Goods Research
- Henrik Bartnes
- Petter Nystrøm
Swedish Orphan Biovitrum AB: 1 director
A director at Swedish Orphan Biovitrum AB maiden bought 1,900 shares at 405.333SEK and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
FLSmidth: Transactions under share buy-back programme
FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 10-2026FLSmidth & Co. A/S11 February 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of R...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Capital Goods Research
- Mikkel Løgsted
- ABGSC Capital Goods Research
- Mikkel Løgsted
FLSmidth announces preliminary and unaudited results for 2025 and full...
FLSmidth announces preliminary and unaudited results for 2025 and full-year 2026 financial guidance COMPANY ANNOUNCEMENT NO. 09-2026 FLSmidth & Co. A/S 5 February 2026 Copenhagen, Denmark Today, FLSmidth & Co. A/S (FLSmidth) announces preliminary and unaudited financial key results for the full year 2025 and introduces its financial guidance for the full year 2026 FLSmidth hereby announces preliminary and unaudited financial figures for the full year 2025. The preliminary financial figures are awaiting finalisation of the company’s independent, customary audit procedures and are theref...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
Toni Laaksonen appointed CEO to lead the next phase in FLSmidth’s stra...
Toni Laaksonen appointed CEO to lead the next phase in FLSmidth’s strategic journey focused on accelerating growth COMPANY ANNOUNCEMENT NO. 08-2026 FLSmidth & Co. A/S 4 February 2026 Copenhagen, Denmark FLSmidth & Co. A/S (FLSmidth) today announces that Toni Laaksonen has been appointed Chief Executive Officer (CEO), effective immediately. Toni joined FLSmidth as Service Business Line President in June 2025. Toni succeeds Mikko Keto, who in November 2025 informed the Board of Directors of his decision to leave the company to pursue an opportunity outside FLSmidth (ref. Company Announcem...
FLSmidth: Transactions under share buy-back programme
FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 07-2026FLSmidth & Co. A/S4 February 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of Re...
FLSmidth & Co. A/S major shareholder announcement
FLSmidth & Co. A/S major shareholder announcement COMPANY ANNOUNCEMENT NO. 06-2026 FLSmidth & Co. A/S 3 February 2026 Copenhagen, Denmark FLSmidth & Co. A/S (“FLSmidth” or the “Company”) hereby announces the following notifications received pursuant to sections 38-39 of the Danish Capital Markets Act from Société Générale S.A. regarding its holdings of shares and financial instruments relating to shares in FLSmidth. On 2 February 2026, Société Générale S.A. informed FLSmidth that, as of 28 January 2026, its aggregate holding of shares and financial instruments with a similar economic e...
FLSmidth: Transactions under share buy-back programme
FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 05-2026FLSmidth & Co. A/S28 January 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of Re...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
FLSmidth: Transactions under share buy-back programme
FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 56-2025FLSmidth & Co. A/S21 January 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of Re...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.